TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12952498

Group type: EXPERIMENTAL
Intervention: Tetracycline 250 mg with centchroman 30 mg
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Tetracycline 250 mg, centchroman 30 mg, and lactic acid bacillus spores (60 million)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (previously reported data)
Number of subjects: 22
Study: 10647760

Group type: EXPERIMENTAL
Intervention: Active treatment with nitrendipine (10-40 mg/d), possibly with captopril (12.5-50 mg/d) and/or hydrochlorothiazide (12.5-50 mg/d)
Number of subjects: 1253

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 1253

Group type: EXPERIMENTAL
Intervention: Active treatment
Number of subjects: 1253
Study: 8678101

Group type: EXPERIMENTAL
Intervention: Cefepime
Number of subjects: 180

Group type: COMPARATOR
Intervention: Ceftazidime
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Cefepime and Ceftazidime
Number of subjects: 180
Study: 2057034

Group type: EXPERIMENTAL
Intervention: Enalapril (2.5 to 20 mg per day)
Number of subjects: 2569

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2569
Study: 6951261

Group type: EXPERIMENTAL
Intervention: Duraphat
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Fluor Protector
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control side (Duraphat)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control side (Fluor Protector)
Number of subjects: 132
Study: 31577394

Group type: EXPERIMENTAL
Intervention: 4-week group self-compassion-based intervention (1-hour sessions once per week)
Number of subjects: 8
Study: 30152428

Group type: EXPERIMENTAL
Intervention: Intradialytic exercise during the first 2 hours of HD
Number of subjects: 20

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 20
Study: 26945741

Group type: EXPERIMENTAL
Intervention: 0.3% A/BPO
Number of subjects: 503

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 503

Group type: EXPERIMENTAL
Intervention: 0.1% A/BPO
Number of subjects: 503
Study: 24863570

Group type: COMPARATOR
Intervention: targeted ultraviolet B (tUVB) treatment
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (untreated side)
Number of subjects: 11
Study: 22215413

Group type: EXPERIMENTAL
Intervention: Systematic group (instructed to produce sequences according to a rule of their choice)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Random group (instructed to produce sequences according to chance)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not instructed about how to produce sequences)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All groups during extinction phase (B phase)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Systematic group
Number of subjects: 0
Study: 20930354

Group type: EXPERIMENTAL
Intervention: 0.074% diclofenac mouthwash
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 18588441

Group type: EXPERIMENTAL
Intervention: CO2 laser
Number of subjects: 60

Group type: COMPARATOR
Intervention: Scalpel (control)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 16091074

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Pethidine
Number of subjects: 56

Group type: COMPARATOR
Intervention: Overall (Morphine vs Pethidine)
Number of subjects: 56
Study: 12418063

Group type: EXPERIMENTAL
Intervention: Laparoscopic ovarian drilling using a harmonic scalpel (Group A)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Laparoscopic ovarian drilling using a neodymium‐yttrium‐aluminum‐garnet laser (Group B)
Number of subjects: 34
Study: 11956045

Group type: EXPERIMENTAL
Intervention: Stress phase (final examination week)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Low-stress phase (midsemester or two weeks postfinal examination)
Number of subjects: 20
Study: 9707384

Group type: EXPERIMENTAL
Intervention: Levomethadyl acetate (LAAM) high-dose (100 mg) induction lasting 17 days
Number of subjects: 180

Group type: COMPARATOR
Intervention: Levomethadyl acetate (LAAM) low-dose (25 mg) induction
Number of subjects: 180

Group type: COMPARATOR
Intervention: Levomethadyl acetate (LAAM) medium-dose (50 mg) induction lasting 7 days
Number of subjects: 180
Study: 7713467

Group type: EXPERIMENTAL
Intervention: Enzyme combination preparation
Number of subjects: 192

Group type: COMPARATOR
Intervention: Acyclovir
Number of subjects: 192
Study: 2495779

Group type: EXPERIMENTAL
Intervention: Misoprostol (200 micrograms four times a day)
Number of subjects: 239

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 239
Study: 761334

Group type: EXPERIMENTAL
Intervention: Reorganized treatment group
Number of subjects: 202

Group type: COMPARATOR
Intervention: Ordinary treatment group
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Chlorthalidone alone
Number of subjects: 202
Study: 31634108

Group type: EXPERIMENTAL
Intervention: Complete Health Improvement Program (CHIP) for 9 months
Number of subjects: 120

Group type: COMPARATOR
Intervention: Healthy Heart program for 9 months
Number of subjects: 120
Study: 26825447

Group type: EXPERIMENTAL
Intervention: CO2 at 3000 ppm with bioeffluents
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: CO2 at 1000 ppm with bioeffluents
Number of subjects: 25

Group type: COMPARATOR
Intervention: CO2 at 500 ppm (reference condition)
Number of subjects: 25
Study: 25746509

Group type: EXPERIMENTAL
Intervention: Monitoring 16 patients
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Monitoring 24 patients
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Monitoring 32 patients
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Monitoring 40 patients
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Monitoring 48 patients
Number of subjects: 42
Study: 23406077

Group type: EXPERIMENTAL
Intervention: 50/50 nitrous oxide and oxygen at 9 L/min (N(2) O group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Medical air at 9 L/min (MA group)
Number of subjects: 60
Study: 21224456

Group type: EXPERIMENTAL
Intervention: Behavioral therapy (pelvic floor muscle training and bladder control strategies)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Behavioral therapy plus biofeedback and pelvic floor electrical stimulation
Number of subjects: 208

Group type: COMPARATOR
Intervention: Delayed treatment (control group)
Number of subjects: 208
Study: 19948277

Group type: EXPERIMENTAL
Intervention: Verteporfin photodynamic therapy
Number of subjects: 0
Study: 17174113

Group type: EXPERIMENTAL
Intervention: Early mobilization (2 weeks)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Late mobilization (6 weeks)
Number of subjects: 49
Study: 15520341

Group type: EXPERIMENTAL
Intervention: ATHENA program (8 weekly 45-minute sessions)
Number of subjects: 928
Study: 11739067

Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 116

Group type: COMPARATOR
Intervention: Paroxetine
Number of subjects: 116
Study: 9234827

Group type: EXPERIMENTAL
Intervention: 50 mg mibefradil
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: 100 mg mibefradil
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: 150 mg mibefradil
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: 200 mg mibefradil
Number of subjects: 303

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 303
Study: 7962680

Group type: EXPERIMENTAL
Intervention: Clomipramine treatment
Number of subjects: 0
Study: 3596358

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 150 mg of aspirin
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 300 mg of aspirin
Number of subjects: 17
Study: 28953493

Group type: EXPERIMENTAL
Intervention: Zinc lozenges (40 mg) administered 30 minutes preoperatively
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study: 26589105

Group type: EXPERIMENTAL
Intervention: Metreleptin treatment in patients with obesity (twice-daily for 20-52 weeks)
Number of subjects: 713

Group type: EXPERIMENTAL
Intervention: Metreleptin treatment in patients with lipodystrophy (once-daily or twice-daily for 2 months to 12.3 years)
Number of subjects: 713

Group type: EXPERIMENTAL
Intervention: In vitro neutralizing activity in patients with obesity
Number of subjects: 713

Group type: EXPERIMENTAL
Intervention: In vitro neutralizing activity in patients with lipodystrophy
Number of subjects: 713
Study: 25003738

Group type: EXPERIMENTAL
Intervention: Larger pouches
Number of subjects: 97

Group type: COMPARATOR
Intervention: Smaller pouches
Number of subjects: 97
Study: 23190837

Group type: EXPERIMENTAL
Intervention: Oral rivaroxaban (10 mg) once daily for 10 days, starting 6 to 8 hours after surgery
Number of subjects: 40

Group type: COMPARATOR
Intervention: Oral placebo once daily for 10 days, starting 6 to 8 hours after surgery
Number of subjects: 40
Study: 20160653

Group type: EXPERIMENTAL
Intervention: High-dose vitamins (2 g vitamin C and 800 IU vitamin E)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Methionine loading (100 mg/kg body weight)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Methionine loading
Number of subjects: 88
Study: 18515689

Group type: EXPERIMENTAL
Intervention: Problem-solving treatment (PST)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 206
Study: 16036895

Group type: EXPERIMENTAL
Intervention: Vigorous bubbling for 30 minutes
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: High amplitude bubbling for 30 minutes
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Slow bubbling for 30 minutes
Number of subjects: 26
Study: 14622687

Group type: EXPERIMENTAL
Intervention: 60 mg etoricoxib
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: 90 mg etoricoxib
Number of subjects: 319

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 319
Study: 10742934

Group type: EXPERIMENTAL
Intervention: 9-month, manual-based, psychoeducational family therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Therapists' ratings of participants' problem behaviors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Independent observers' ratings of overall treatment difficulty
Number of subjects: 0
Study: 9003103

Group type: EXPERIMENTAL
Intervention: Anticardiolipin antibodies (IgG or IgM)
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: Anticardiolipin antibodies (IgA)
Number of subjects: 570
Study: 1728527

Group type: EXPERIMENTAL
Intervention: 5-ASA (2 g/day)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 6093236

Group type: EXPERIMENTAL
Intervention: Low secretory IgA concentrations in IM patients, mean value 0.180 g/l
Number of subjects: 18

Group type: COMPARATOR
Intervention: Tinidazole treatment
Number of subjects: 18
Study: 2942457

Group type: EXPERIMENTAL
Intervention: 0.3% foscarnet cream for men
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: 1% foscarnet cream for women
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: foscarnet cream (both dosages)
Number of subjects: 230

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 230
Study: 31532835

Group type: EXPERIMENTAL
Intervention: Sucrose and music
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sucrose
Number of subjects: 16
Study: 28993963

Group type: EXPERIMENTAL
Intervention: DHA and EPA supplementation for 3 months
Number of subjects: 162

Group type: COMPARATOR
Intervention: Placebo for 3 months
Number of subjects: 162
Study: 27854537

Group type: EXPERIMENTAL
Intervention: New physical activity standards in South Carolina
Number of subjects: 64
Study: 26528650

Group type: EXPERIMENTAL
Intervention: Adults with SZO/SA
Number of subjects: 46

Group type: COMPARATOR
Intervention: NHANES users of MHS
Number of subjects: 46

Group type: COMPARATOR
Intervention: NHANES nonusers of MHS
Number of subjects: 46
Study: 24172558

Group type: EXPERIMENTAL
Intervention: Limbal incision (von Noorden)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Para limbal incision (Santiago)
Number of subjects: 24
Study: 20495161

Group type: EXPERIMENTAL
Intervention: OROS methylphenidate (Concerta)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Immediate-release methylphenidate (IR-MPH)
Number of subjects: 53
Study: 18501061

Group type: COMPARATOR
Intervention: Calcium-rich diet (CA)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Calcium-rich diet + exercise (CA + EX)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Calcium-rich diet + exercise and high fruit and vegetable, low-fat diet (CA + EX + FVLF)
Number of subjects: 90
Study: 16929448

Group type: EXPERIMENTAL
Intervention: Preoperative epoetin-alpha treatment added to standard care
Number of subjects: 695

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 695
Study: 11756667

Group type: EXPERIMENTAL
Intervention: lorazepam (1 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: scopolamine (0.4 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: i.v. saline (placebo)
Number of subjects: 10
Study: 9789200

Group type: EXPERIMENTAL
Intervention: Melimmune-1 and Melimmune-2 administered with SAF-m adjuvant
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Melimmune-1
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Melimmune-2
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Melimmune-1 and/or Melimmune-2 F(Ab')2
Number of subjects: 21
Study: 7694970

Group type: EXPERIMENTAL
Intervention: Ivermectin
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Ivermectin (after 12 months)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Ivermectin and Placebo (both groups)
Number of subjects: 70
Study: 2703174

Group type: EXPERIMENTAL
Intervention: Intracavitary irradiation using high dose-rate afterloading technique with 60Co sources
Number of subjects: 366

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 366

Group type: COMPARATOR
Intervention: 5 Gy per fraction
Number of subjects: 366

Group type: COMPARATOR
Intervention: 10 Gy per fraction
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: Combination treatment (hysterectomy and radiotherapy)
Number of subjects: 366

Group type: COMPARATOR
Intervention: Hysterectomy group
Number of subjects: 366
Study: 342631

Group type: EXPERIMENTAL
Intervention: monovalent (A/New Jersey/76) vaccine, single dose
Number of subjects: 444

Group type: EXPERIMENTAL
Intervention: split-product vaccines, two-dose regimen
Number of subjects: 444

Group type: EXPERIMENTAL
Intervention: bivalent (A/New Jersey/76-A/Victoria/75) vaccines, high doses of split-product
Number of subjects: 444

Group type: COMPARATOR
Intervention: whole-virus vaccines
Number of subjects: 444
Study: 31765053

Group type: EXPERIMENTAL
Intervention: Dentists rated their own communication skills for anxious patients
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Dentists rated their own communication skills for unmotivated patients
Number of subjects: 70

Group type: COMPARATOR
Intervention: Students' overall empathy scores
Number of subjects: 70
Study: 30358156

Group type: EXPERIMENTAL
Intervention: L-arginine (17.1 mmol)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Glycine (control amino acid)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 0
Study: 27653939

Group type: EXPERIMENTAL
Intervention: Azithromycin 500 mg daily for 3 days
Number of subjects: 199

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 199

Group type: COMPARATOR
Intervention: Azithromycin and Placebo
Number of subjects: 199
Study: 25668167

Group type: EXPERIMENTAL
Intervention: HPV-based screening (experimental arm)
Number of subjects: 176464

Group type: COMPARATOR
Intervention: Cytology-based screening (control arm)
Number of subjects: 176464
Study: 23240499

Group type: EXPERIMENTAL
Intervention: Influenza vaccine subunit strain A/California/7/2009/(H1N1)v
Number of subjects: 70
Study: 20461336

Group type: EXPERIMENTAL
Intervention: Strength group (isometric, dynamic and stretching exercises)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Endurance group (dynamic muscle and stretching exercises)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (stretching exercises)
Number of subjects: 180
Study: 18418962

Group type: EXPERIMENTAL
Intervention: Oxymatrine plus Western routine therapy
Number of subjects: 82

Group type: COMPARATOR
Intervention: Western routine therapy (Control)
Number of subjects: 82
Study: 15923120

Group type: EXPERIMENTAL
Intervention: Active lead placement on the posterior left ventricle
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Active lead placement on the anterior left ventricle
Number of subjects: 25

Group type: COMPARATOR
Intervention: Active lead placement on the right ventricle (control)
Number of subjects: 25
Study: 12844131

Group type: EXPERIMENTAL
Intervention: Standard oral dexamethasone regimen (20 mg on day 1, 8 mg on days 2 to 5) plus ondansetron (32 mg IV on day 1)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Modified dexamethasone regimen (12 mg on day 1, 4 mg on days 2 to 5) plus ondansetron (32 mg IV on day 1)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Methylprednisolone regimen (125 mg IV on day 1, 40 mg orally on days 2 to 3) with aprepitant (125 mg on day 1, 80 mg on days 2 to 3)
Number of subjects: 20
Study: 10325897

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP), 500 micrograms twice daily
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Budesonide (BUD), 800 micrograms twice daily
Number of subjects: 59
Study: 8612314

Group type: COMPARATOR
Intervention: Ftorafur (FT) 600 mg/day
Number of subjects: 1254

Group type: EXPERIMENTAL
Intervention: Ftorafur (FT) 600 mg/day plus Tamoxifen (TAM) 20 mg/day
Number of subjects: 1254
Study: 1787937

Group type: EXPERIMENTAL
Intervention: Topical prednisolone 1%
Number of subjects: 58

Group type: COMPARATOR
Intervention: No prednisolone (control group)
Number of subjects: 58
Study: 7025416

Group type: EXPERIMENTAL
Intervention: Conservative treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 31429150

Group type: EXPERIMENTAL
Intervention: Plasma uric acid (PUA) concentrations
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Fractional excretion of UA
Number of subjects: 88
Study: 30501835

Group type: EXPERIMENTAL
Intervention: Web-based remote training and counselling
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 120
Study: 26654213

Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study: 25040829

Group type: EXPERIMENTAL
Intervention: Epidural analgesia in labour (31.5%, n = 66,317)
Number of subjects: 210708

Group type: EXPERIMENTAL
Intervention: Epidural analgesia in labour
Number of subjects: 210708
Study: 23193066

Group type: EXPERIMENTAL
Intervention: Textured insoles
Number of subjects: 10

Group type: COMPARATOR
Intervention: Regular insoles
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Barefoot condition
Number of subjects: 10

Group type: COMPARATOR
Intervention: Regular footwear condition
Number of subjects: 10
Study: 20798339

Group type: EXPERIMENTAL
Intervention: Mean systolic blood pressure (SBP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Visit-to-visit variability in systolic blood pressure (SD.SBP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Visit-to-visit variability in diastolic blood pressure (DBP variability)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mean diastolic blood pressure (DBP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Visit-to-visit variability in diastolic blood pressure (SD.DBP)
Number of subjects: 0
Study: 18586814

Group type: EXPERIMENTAL
Intervention: Functional neuromuscular electrical stimulation (FES)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Passive leg movement (control)
Number of subjects: 5
Study: 16320349

Group type: EXPERIMENTAL
Intervention: Platelet adhesion and aggregation on the extracellular matrix measured with a cone‐and‐plate(let) analyzer (CPA)
Number of subjects: 88
Study: 12366503

Group type: EXPERIMENTAL
Intervention: Fluid administration <1 litre
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Fluid administration ≥1 litre
Number of subjects: 17

Group type: COMPARATOR
Intervention: No fluid administration (Control)
Number of subjects: 17
Study: 11041318

Group type: EXPERIMENTAL
Intervention: Zolmitriptan (5 mg per os)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8773263

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid
Number of subjects: 122

Group type: COMPARATOR
Intervention: Colchicine
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study: 2055827

Group type: EXPERIMENTAL
Intervention: High-carbohydrate diet (10 g.kg body mass‐1.day‐1)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Moderate-carbohydrate diet (5 g.kg body mass‐1.day‐1)
Number of subjects: 22
Study: 7081096

Group type: EXPERIMENTAL
Intervention: 100 mg/day zinc supplementation
Number of subjects: 32

Group type: COMPARATOR
Intervention: 15 mg/day zinc supplementation
Number of subjects: 32

Group type: COMPARATOR
Intervention: 50 mg/day zinc supplementation
Number of subjects: 32

Group type: COMPARATOR
Intervention: 0 mg/day zinc supplementation (placebo)
Number of subjects: 32
Study: 31405875

Group type: EXPERIMENTAL
Intervention: Practice facilitation and educational outreach visits
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Practice facilitation and shared learning
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Practice facilitation and both shared learning and educational outreach visits
Number of subjects: 209

Group type: COMPARATOR
Intervention: Practice facilitation only
Number of subjects: 209
Study: 28631901

Group type: EXPERIMENTAL
Intervention: Perforated ultra‐lightweight polypropylene implant (surface density 19 g/m2)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Lightweight polypropylene implant (surface density 42.7 g/m2)
Number of subjects: 93
Study: 26700109

Group type: EXPERIMENTAL
Intervention: 100,000 IU vitamin D2 (ergocalciferol)
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: 100,000 IU vitamin D3 (cholecalciferol)
Number of subjects: 340

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 340
Study: 24938529

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 0
Study: 21917257

Group type: EXPERIMENTAL
Intervention: Computer navigation (Nav 1)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Computer navigation (Nav 2)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional techniques (Fluoro)
Number of subjects: 20